Drug intelligence / Profile preview

Klosterfrau Cistus Infekt Blocker

Development stage: Unknown
Lead developer: MCM Klosterfrau
Administration: Intranasal

Overview

Klosterfrau Cistus Infekt Blocker is an over-the-counter (OTC) herbal nasal spray developed by MCM Klosterfrau. It is designed to provide a physical barrier against viral respiratory infections. The primary active component is an extract from the *Cistus* plant (rockrose), which contains high concentrations of polyphenols. These polyphenols are thought to form a protective film on the nasal mucosa, physically trapping viruses and preventing them from entering host cells. It is marketed for the prevention and supportive treatment of viral infections of the upper respiratory tract and is typically classified as a medical device in European markets due to its physical mode of action.

Brand names: Klosterfrau Cistus Infekt Blocker
Other names: Cistus Infekt Blocker

Beyond the preview

Go deeper on Klosterfrau Cistus Infekt Blocker.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Klosterfrau Cistus Infekt Blocker.

Explore the full profile